Package 49702-248-13

{"route": ["ORAL"], "spl_id": "6039b41a-e8a1-4976-bcbc-0fd7b70e423c", "openfda": {"unii": ["3L12PT535M"], "rxcui": ["2475199", "2475205"], "spl_set_id": ["66d450fb-cca4-476c-b0c7-c0730e3e4cf3"], "manufacturer_name": ["ViiV Healthcare Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (49702-248-13)", "package_ndc": "49702-248-13", "marketing_start_date": "20210121"}], "brand_name": "Vocabria", "product_id": "49702-248_6039b41a-e8a1-4976-bcbc-0fd7b70e423c", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["HIV Integrase Inhibitors [MoA]", "Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]", "Organic Anion Transporter 1 Inhibitors [MoA]", "Organic Anion Transporter 3 Inhibitors [MoA]"], "product_ndc": "49702-248", "generic_name": "cabotegravir sodium", "labeler_name": "ViiV Healthcare Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Vocabria", "active_ingredients": [{"name": "CABOTEGRAVIR SODIUM", "strength": "30 mg/1"}], "application_number": "NDA212887", "marketing_category": "NDA", "marketing_start_date": "20210121", "listing_expiration_date": "20261231"}